Eventful Year Ends with Award Success

Cambridge drug discovery start-up Repositive finished 2018 on a high note, having been named European Super Angels Club (ESAC) Digital Health Champion 2018. After achieving success in a national pitching event, Fiona Nielsen, Repositive’s CEO and Founder, competed against five finalists from across Europe, out of a pool of hundreds of start-ups, to receive the title in Vienna on 29 November.

The award built on earlier accolades achieved during 2018, including Fiona Nielsen being awarded both ‘highly commended’ CEO of the Year in the Cambridge Independent Science and Technology Awards and included on the 2018 WSE100 list, as well as Repositive being named one of Cambridge News’ 130 most influential Cambridge businesses.

Repositive’s Cancer Models platform and Translational Oncology Network helps researchers to find the right cancer model by connecting them to the cancer model inventory of Contract Research Organisations (CROs) worldwide.

The growth in cancer models has been mirrored by the company’s scaling over the last year with the number of employees tripling to 40, the establishment of an advisory board and relocation to larger premises twice. The company was said to be expecting significant expansion of its inventory during 2019.

Fiona added: “It has been a fast-paced but incredibly rewarding year for Repositive. We have come a long way in 12 months and have made great strides towards our long-term ambition to accelerate drug discovery by removing the barriers that researchers face in accessing essential data, products and services.”

“We hope to assist more researchers by providing them with the connections, practical support and networking opportunities they need to thrive. And we expect to see our team get bigger, as we speed up oncology research and speed up progress towards benefits for patients.”